Total Payments
$195,915
2024 Payments
$140,196
Companies
35
Transactions
309
Medicare Patients
9,575
Medicare Billing
$675,387
Payment Breakdown by Category
Research$187,984 (96.0%)
Food & Beverage$5,590 (2.9%)
Travel$1,168 (0.6%)
Consulting$800.00 (0.4%)
Education$373.41 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $187,984 | 6 | 96.0% |
| Food and Beverage | $5,590 | 293 | 2.9% |
| Travel and Lodging | $1,168 | 3 | 0.6% |
| Consulting Fee | $800.00 | 1 | 0.4% |
| Education | $373.41 | 6 | 0.2% |
Payments by Type
Research
$187,984
6 transactions
General
$7,931
303 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nielsen BioSciences, Inc. | $138,804 | 1 | $0 (2024) |
| Bausch Health US, LLC | $49,180 | 5 | $0 (2019) |
| LEO Pharma AS | $1,168 | 3 | $0 (2017) |
| ABBVIE INC. | $1,046 | 55 | $0 (2024) |
| Almirall LLC | $855.13 | 4 | $0 (2023) |
| Galderma Laboratories, L.P. | $665.59 | 16 | $0 (2022) |
| Janssen Biotech, Inc. | $640.31 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $506.76 | 22 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $397.92 | 21 | $0 (2024) |
| Lilly USA, LLC | $384.40 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140,196 | 65 | Nielsen BioSciences, Inc. ($138,804) |
| 2023 | $1,495 | 80 | AbbVie Inc. ($328.67) |
| 2022 | $819.99 | 38 | ABBVIE INC. ($299.93) |
| 2021 | $869.84 | 5 | Almirall LLC ($816.51) |
| 2020 | $136.52 | 3 | Galderma Laboratories, L.P. ($85.42) |
| 2019 | $43,406 | 26 | Bausch Health US, LLC ($42,930) |
| 2018 | $6,724 | 32 | Bausch Health US, LLC ($6,250) |
| 2017 | $2,269 | 60 | LEO Pharma AS ($1,168) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $51.87 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Dermatology | ||||||
| 11/30/2024 | Nielsen BioSciences, Inc. | Candin (Biological) | — | Cash or cash equivalent | $138,804.04 | Research |
| Study: CFW-3A • Category: Immunotherapy | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.26 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Immunology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.03 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.25 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.97 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.84 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CFW-3A | Nielsen BioSciences, Inc. | $138,804 | 1 |
| A PHASE 1B OPEN-LABEL STUDY EVALUATING THE ABSORPTION AND SYSTEMIC PHARMACOKINETICS OF TOPICALLY APPLIED IDP-126 GEL IN COMPARISON WITH EPIDUO FORTE GEL IN SUBJECTS WITH MODERATE TO SEVERE ACNE VULGARIS UNDER MAXIMAL USE CONDITIONS | Bausch Health US, LLC | $42,930 | 3 |
| A Phase 1b Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison with EpiDuo Forte Gel 0.3 adapalene2.5 BPO in Subjects with Acne Vulgaris under Maximal Use Conditions | Bausch Health US, LLC | $6,250 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,468 | 4,631 | $690,313 | $179,751 |
| 2022 | 20 | 2,478 | 4,684 | $671,982 | $173,841 |
| 2021 | 20 | 2,355 | 4,384 | $591,372 | $170,397 |
| 2020 | 23 | 2,274 | 4,100 | $583,165 | $151,399 |
Total Patients
9,575
Total Services
17,799
Medicare Billing
$675,387
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 549 | 806 | $128,960 | $43,746 | 33.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 268 | 363 | $77,319 | $21,515 | 27.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 326 | 521 | $75,024 | $18,036 | 24.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 324 | 705 | $141,000 | $16,759 | 11.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 56 | 62 | $40,858 | $13,723 | 33.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 105 | 127 | $30,734 | $9,447 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 114 | $27,018 | $9,059 | 33.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 53 | 71 | $27,264 | $7,562 | 27.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 43 | 58 | $18,328 | $6,810 | 37.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 97 | 161 | $18,515 | $5,705 | 30.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 236 | 1,296 | $14,256 | $5,651 | 39.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 138 | 151 | $14,496 | $5,171 | 35.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 19 | 21 | $13,566 | $4,996 | 36.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 46 | 53 | $28,779 | $4,497 | 15.6% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $11,305 | $1,817 | 16.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 19 | 19 | $5,092 | $1,493 | 29.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $7,306 | $1,193 | 16.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 12 | 13 | $3,380 | $1,120 | 33.1% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 19 | $4,161 | $911.58 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,844 | $515.46 | 18.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 27 | $108.00 | $22.25 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 530 | 714 | $114,240 | $39,820 | 34.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 285 | 359 | $76,467 | $21,934 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 341 | 534 | $76,896 | $18,532 | 24.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 323 | 704 | $140,800 | $16,620 | 11.8% |
About Dr. Jess Demaria, MD
Dr. Jess Demaria, MD is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154373009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jess Demaria, MD has received a total of $195,915 in payments from pharmaceutical and medical device companies, with $140,196 received in 2024. These payments were reported across 309 transactions from 35 companies. The most common payment nature is "" ($187,984).
As a Medicare-enrolled provider, Demaria has provided services to 9,575 Medicare beneficiaries, totaling 17,799 services with total Medicare billing of $675,387. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 05/17/2006
- Last Updated 05/01/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1154373009
Products in Payments
- Candin (Biological) $138,804
- Klisyri (Drug) $838.62
- RINVOQ (Biological) $519.14
- Sotyktu (Drug) $482.07
- SKYRIZI (Biological) $399.71
- EUCRISA (Drug) $345.16
- TALTZ (Drug) $314.78
- EPIDUO FORTE (Drug) $274.33
- TREMFYA (Drug) $266.05
- ILUMYA (Biological) $251.77
- OPZELURA (Drug) $239.55
- STELARA (Biological) $233.41
- DUPIXENT (Biological) $200.39
- SOOLANTRA (Drug) $162.10
- SPEVIGO (Drug) $142.12
- ORACEA (Drug) $132.06
- EPSOLAY (Drug) $97.10
- VTAMA (Drug) $93.31
- Tremfya (Drug) $89.95
- COSENTYX (Biological) $83.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Dr. Joshua Grosshandler, M.d, M.D
Dermatology — Payments: $378,447
Dermatology $378,447
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Dermatology $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dermatology $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Dermatology $14,525
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506
Dermatology $9,506
Sara Huff, Md, MD
Dermatology — Payments: $5,661
Dermatology $5,661